日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GPD1L supports glycerol-3-phosphate and triacylglycerol synthesis and promotes tumor progression in HCC

GPD1L支持甘油-3-磷酸和三酰甘油的合成,并促进肝细胞癌的肿瘤进展。

Yu, Tiffany Ching-Yun; Zhao, Luqing; Sze, Karen Man-Fong; Tian, Lu; Zhang, Vanilla Xin; Lee, Eva; Kam, Charles Shing; Lee, Joyce Man-Fong; Ho, Daniel Wai-Hung; Tsui, Yu-Man; Chan, Lo-Kong; Ng, Irene Oi-Lin

Spatiotemporal dynamics of T cells in peripheral blood and tumor underlying differential responses to neoadjuvant PD-1 blockade in hepatocellular carcinoma

外周血和肿瘤中T细胞的时空动态变化是肝细胞癌新辅助PD-1阻断治疗差异反应的基础

Zhang, Yajing; Tsui, Yu-Man; Lee, Joyce Man-Fong; Cheung, Tan-To; Ho, Daniel Wai-Hung; Ng, Irene Oi-Lin

Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis

BRCA1相关蛋白1的核定位在通过CTCF和NRF1/OGT轴抑制肝细胞癌转移中起重要作用。

Xie, Xiaoyu; Tsui, Yu-Man; Zhang, Vanilla Xin; Yu, Tiffany Ching-Yun; Husain, Abdullah; Chiu, Yung-Tuen; Tian, Lu; Lee, Eva; Lee, Joyce Man-Fong; Ma, Hoi-Tang; Ho, Daniel Wai-Hung; Sze, Karen Man-Fong; Ng, Irene Oi-Lin

Cancer stem cells in hepatocellular carcinoma: platforms, updates, challenges and future perspectives

肝细胞癌中的癌症干细胞:平台、最新进展、挑战和未来展望

Lu, Jingyi; O, Diana Chui-Yee; Tsui, Yu-Man; Ng, Irene Oi-Lin

MASLD/MASH-New mechanisms and treatments

MASLD/MASH——新的机制和治疗方法

Zhang, Vanilla Xin; Tsui, Yu-Man; Ng, Irene Oi-Lin

Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma

新辅助纳武利尤单抗治疗中晚期肝细胞癌的多模态整合基因组学和病理学分析

Cheung, Tan-To; Wai-Hung Ho, Daniel; Lyu, Shirley Xueying; Zhang, Qingyang; Tsui, Yu-Man; Ching-Yun Yu, Tiffany; Man-Fong Sze, Karen; Man-Fong Lee, Joyce; Lau, Vince Wing-Hang; Yin-Lun Chu, Edward; Hing-Yin Tsang, Simon; She, Wong-Hoi; Ching-Yu Leung, Roland; Chung-Cheung Yau, Thomas; Ng, Irene Oi-Lin

Resolution of Optimal Mitochondrial and Nuclear DNA Enrichment in Target-Panel Sequencing and Physiological Mitochondrial DNA Copy Number Estimation in Liver Cancer and Non-Liver Cancer Subjects

靶向测序中线粒体和核DNA富集的最佳分辨率以及肝癌和非肝癌受试者生理性线粒体DNA拷贝数估计

Lyu, Xue-Ying; Tsui, Yu-Man; Tam, Ivan Ka-Kit; Li, Po-Man; Cheung, Gary Cheuk-Hang; Lee, Joyce Man-Fong; Ng, Irene Oi-Lin; Ho, Daniel Wai-Hung

S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos

S100A10 通过细胞外囊泡转运并调节其蛋白质载荷来促进肝细胞癌的发生发展。

Wang, Xia; Huang, Hongyang; Sze, Karen Man-Fong; Wang, Jin; Tian, Lu; Lu, Jingyi; Tsui, Yu-Man; Ma, Hoi Tang; Lee, Eva; Chen, Ao; Lee, Joyce; Wang, Ying; Yam, Judy Wai Ping; Cheung, Tan-To; Guan, Xinyuan; Ng, Irene Oi-Lin

Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells

肝细胞癌动态变化的驱动因素:肿瘤微环境与肿瘤起始细胞之间的相互作用

Huang, Hongyang; Tsui, Yu-Man; Ng, Irene Oi-Lin

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma

利用游离或循环肿瘤DNA进行液体活检在肝细胞癌管理中的应用

Lyu, Xueying; Tsui, Yu-Man; Ho, Daniel Wai-Hung; Ng, Irene Oi-Lin